Taisuke Hoshi

Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models

Masahiro Matsuki, Taisuke Hoshi, Yuji Yamamoto et al. · Cancer Medicine · 2018 · 249 citations · Full text

Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR–MAPK cascades

Taisuke Hoshi, Saori Watanabe Miyano, Hideki Watanabe et al. · Biochemical and Biophysical Research Communications · 2019 · 74 citations · Full text

Fgfr–mapk Cascades, Chemoprevention Strategy, Pathology +18

Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus

Masahiro Matsuki, Yusuke Adachi, Yoichi Ozawa et al. · Cancer Science · 2017 · 63 citations · Full text

Everolimus Combination, Tumor Biology, Oncology +17

The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses

Tohru Tezuka, Akane Inoue, Taisuke Hoshi et al. · Proceedings of the National Academy of Sciences · 2014 · 54 citations · Full text

The Effect of Resveratrol on the Werner Syndrome RecQ Helicase Gene and Telomerase Activity

Fumiaki Uchiumi, Takeshi Watanabe, Shin Hasegawa et al. · Current Aging Science · 2011 · 33 citations

Redox Signaling, Rsv Treatment, Natural Sciences +14